Ultrasonographic evaluation of the perioperative gastric motility of metoclopramide

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022680

Enrollment

Unknown

Registered

2019-04-21

Start date

2019-04-30

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the perioperative gastric motility

Interventions

Emergency patient group (group B1):Metoclopramide 10mg iv

Emergency patient group (group B2) :no

Selective operation group:5% Glucose Solution 5ml/kg

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients for elective surgery: ASA I-II; Healthy adults aged over 20 years and younger than 60 years, BMI550 mm2 (corresponding to stomach volume 70-150ml) (T0 for ultrasonic evaluation)

Exclusion criteria

Exclusion criteria: Diabetes mellitus, history of gastroparesis,Contraindications in the treatment of hepatorenal insufficiency, pregnant women, and methoxychlorpromide (including allergy to procaine or procaine; Having a history of epilepsy; Patients with gastrointestinal bleeding, mechanical intestinal obstruction or perforation; Patients with pheochromocytoma; Breast cancer patients undergoing chemotherapy and radiotherapy); The need for immediate emergency surgery resulted in less than 2 hours of study time.

Design outcomes

Primary

Measure	Time frame
Gastric antrum area;Number of gastric peristalsis;	—

Countries

China

Contacts

Public ContactHuan Lin

280320200@qq.com+86 13599682117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026